000046873 000__ 01149cam\a22003855i\4500
000046873 001__ 46873
000046873 003__ SzGeWIPO
000046873 005__ 20240708150306.0
000046873 006__ m\\\\eo\\d\\\\\\\\
000046873 007__ cr bn |||m|||a
000046873 008__ 221017s2022\\\\nyu\\\\\o\\\\\000\0\eng\d
000046873 035__ $$a(OCoLC)1348117474
000046873 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000046873 041__ $$aeng
000046873 24504 $$aThe divisional game: using procedural rights to impede generic/biosimilar market entry.
000046873 264_1 $$a[New York, NY] :$$bThomson Reuters,$$c2022
000046873 300__ $$a1 online resource
000046873 336__ $$atext$$2rdacontent
000046873 337__ $$acomputer$$2rdamedia
000046873 338__ $$aonline resource$$bcr$$2rdacarrier
000046873 4901_ $$aInternational Review of Intellectual Property Law & Competition Law,$$x0018-9855 ;$$vVolume 53, Issue 7
000046873 542__ $$fhttps://1.next.westlaw.com/Copyright
000046873 588__ $$aCrossref
000046873 590__ $$aPublished online: 2022
000046873 650_0 $$aIntellectual property.
000046873 650_0 $$aPatent medicines.
000046873 650_4 $$aPharmaceuticals
000046873 7001_ $$aFoss-Solbrekk, Katarina,$$eauthor.
000046873 7731_ $$tInternational Review of Intellectual Property Law & Competition Law
000046873 7731_ $$wIIC
000046873 830_0 $$aInternational Review of Intellectual Property Law & Competition Law ;$$vIIC 2022, 53(7), 1007-1037
000046873 85641 $$uhttps://www.westlaw.com/Document/I67F6D7C02D7411ED896AAE13BD609A21/View/FullText.html?transitionType=Default&contextData=(sc.Default)&VR=3.0&RS=cblt1.0&sp=wlnintell-000$$yonline version
000046873 904__ $$aJournal article
000046873 980__ $$aIIC